{"entity":{"type":"insider","cik":"0001510589","url":"/insider/0001510589","json_url":"/insider/0001510589.json","name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":8,"first":"2016-02-10","last":"2026-02-03","span_basis":"filed_date"},"name_variants":[{"name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","source":"filing","n_filings":6,"first_seen":"2021-10-27","last_seen":"2026-02-03"},{"name":"Hillhouse Capital Management, Ltd.","source":"filing","n_filings":2,"first_seen":"2016-02-10","last_seen":"2017-11-15"}],"transactions":[{"id":5804899,"accession":"0000902664-26-000675","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-26-000675","line_url":"/filing/0000902664-26-000675#line-1","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"ArriVent BioPharma, Inc.","issuer_ticker":"AVBP","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HHLR ADVISORS, LTD.; HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_display_name":"HHLR ADVISORS, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":555555.0,"shares_display":"555,555","price_per_share":23.37,"price_display":"23.37","price_state":"stated","total_value":12983320.35,"total_display":"12,983,320.35","total_whole":"12,983,320","shares_owned_after":3929117.0,"shares_owned_after_display":"3,929,117","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2026-02-03","scope":"insider"},{"id":2201067,"accession":"0000902664-24-006828","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-24-006828","line_url":"/filing/0000902664-24-006828#line-1","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HHLR ADVISORS, LTD.; HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_display_name":"HHLR ADVISORS, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17842500.0,"shares_display":"17,842,500","price_per_share":200.0,"price_display":"200.00","price_state":"stated","total_value":3568500000.0,"total_display":"3,568,500,000.00","total_whole":"3,568,500,000","shares_owned_after":125045741.0,"shares_owned_after_display":"125,045,741","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-02","filed_date":"2024-12-04","scope":"insider"},{"id":2035167,"accession":"0000902664-24-000903","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-24-000903","line_url":"/filing/0000902664-24-000903#line-3","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"ArriVent Biopharma, Inc.","issuer_ticker":"AVBP","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":555555.0,"shares_display":"555,555","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":4484672.0,"shares_owned_after_display":"4,484,672","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-01-30","filed_date":"2024-02-01","scope":"insider"},{"id":7962309,"accession":"0000902664-23-003603","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-23-003603","line_url":"/filing/0000902664-23-003603#line-3","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":273728.0,"shares_display":"273,728","price_per_share":207.7171,"price_display":"207.72","price_state":"stated","total_value":56857986.3488,"total_display":"56,857,986.35","total_whole":"56,857,986","shares_owned_after":142888241.0,"shares_owned_after_display":"142,888,241","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-14","filed_date":"2023-06-15","scope":"insider"},{"id":7962306,"accession":"0000902664-23-003603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-23-003603","line_url":"/filing/0000902664-23-003603","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":924400.0,"shares_display":"924,400","price_per_share":183.30631014712245,"price_display":"183.31","price_state":"stated","total_value":169448353.1,"total_display":"169,448,353.10","total_whole":"169,448,353","shares_owned_after":143475369.0,"shares_owned_after_display":"143,475,369","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-15","scope":"insider","n_lines":2},{"id":8010722,"accession":"0000902664-23-003537","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000902664-23-003537","line_url":"/filing/0000902664-23-003537","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1250212.0,"shares_display":"1,250,212","price_per_share":195.21263436121234,"price_display":"195.21","price_state":"stated","total_value":244057178.03,"total_display":"244,057,178.03","total_whole":"244,057,178","shares_owned_after":144086369.0,"shares_owned_after_display":"144,086,369","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-12","filed_date":"2023-06-12","scope":"insider","n_lines":2},{"id":8010716,"accession":"0000902664-23-003537","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000902664-23-003537","line_url":"/filing/0000902664-23-003537","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":542652.0,"shares_display":"542,652","price_per_share":182.8886474786788,"price_display":"182.89","price_state":"stated","total_value":99244890.3316,"total_display":"99,244,890.33","total_whole":"99,244,890","shares_owned_after":145336581.0,"shares_owned_after_display":"145,336,581","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-12","scope":"insider","n_lines":2},{"id":8010709,"accession":"0000902664-23-003537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-23-003537","line_url":"/filing/0000902664-23-003537#line-1","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":null,"owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.; HHLR ADVISORS, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1163825.0,"shares_display":"1,163,825","price_per_share":218.1443,"price_display":"218.14","price_state":"stated","total_value":253881789.9475,"total_display":"253,881,789.95","total_whole":"253,881,790","shares_owned_after":145879233.0,"shares_owned_after_display":"145,879,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-08","filed_date":"2023-06-12","scope":"insider"},{"id":4164816,"accession":"0000902664-21-004622","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000902664-21-004622","line_url":"/filing/0000902664-21-004622#line-1","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"Enfusion, Inc.","issuer_ticker":"ENFN","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":"0001510589","owner_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_display_name":"HILLHOUSE INVESTMENT MANAGEMENT, LTD.","owner_url":"/insider/0001510589","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A common stock, par value $0.001 per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":647862.0,"shares_display":"647,862","price_per_share":15.895,"price_display":"15.90","price_state":"stated","total_value":10297766.49,"total_display":"10,297,766.49","total_whole":"10,297,766","shares_owned_after":4975183.0,"shares_owned_after_display":"4,975,183","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-10-25","filed_date":"2021-10-27","scope":"insider"},{"id":4567815,"accession":"0000902664-17-004362","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-17-004362","line_url":"/filing/0000902664-17-004362#line-2","is_derivative":false,"issuer_cik":"0001492422","issuer_name":"Apellis Pharmaceuticals, Inc.","issuer_ticker":"APLS","issuer_name_source":null,"issuer_url":"/issuer/0001492422","owner_cik":"0001510589","owner_name":"Hillhouse Capital Management, Ltd.","owner_display_name":"Hillhouse Capital Management, Ltd.","owner_url":"/insider/0001510589","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1428571.0,"shares_display":"1,428,571","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":19999994.0,"total_display":"19,999,994.00","total_whole":"19,999,994","shares_owned_after":3527152.0,"shares_owned_after_display":"3,527,152","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-13","filed_date":"2017-11-15","scope":"insider"},{"id":2236030,"accession":"0000902664-16-005447","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000902664-16-005447","line_url":"/filing/0000902664-16-005447#line-2","is_derivative":false,"issuer_cik":"0001510589","issuer_name":"BeiGene, Ltd.","issuer_ticker":"BGNE","issuer_name_source":null,"issuer_url":"/issuer/0001510589","owner_cik":"0001510589","owner_name":"Hillhouse Capital Management, Ltd.","owner_display_name":"Hillhouse Capital Management, Ltd.","owner_url":"/insider/0001510589","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9100000.0,"shares_display":"9,100,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":39726779.0,"shares_owned_after_display":"39,726,779","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-02-08","filed_date":"2016-02-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001868279","name":"ArriVent BioPharma, Inc.","url":"/issuer/0001868279","role":"Ten percent owner","n_filings":2,"first_seen":"2024-02-01","last_seen":"2026-02-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001651308","name":"BeiGene, Ltd.","url":"/issuer/0001651308","role":"Ten percent owner","n_filings":4,"first_seen":"2016-02-10","last_seen":"2024-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001868912","name":"Enfusion, Inc.","url":"/issuer/0001868912","role":"Ten percent owner","n_filings":1,"first_seen":"2021-10-27","last_seen":"2021-10-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001492422","name":"Apellis Pharmaceuticals, Inc.","url":"/issuer/0001492422","role":"Ten percent owner","n_filings":1,"first_seen":"2017-11-15","last_seen":"2017-11-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001510589","retrieved_at":"2026-08-25T15:22:56+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}